Gonadotropin Releasing Hormone Agonist (GnRHa) Versus Estrogen and Progesterone for Luteal Support in High Responders

NCT04797338 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

100

Enrollment

OTHER_GOV

Sponsor class

Conditions

Pregnancy Early
Miscarriage
Ovarian Hyperstimulation Syndrome

Interventions

DRUG: Synarel, 0.2 Mg/Inh Nasal Spray
DRUG: Estrofem
DRUG: Utrogestan
DRUG: Hydroxyprogesterone Caproate

Sponsor

Assaf-Harofeh Medical Center